Citations (35)
Keep up to date with the latest research on this topic with citation updates for this article.
Articles from other publishers (35)
Xinglong Gao, Xinlian Wang, Shilin Li, Muhammad Saif Ur Rahman, Shanshan Xu & Ying Liu. (2023) Nanovaccines for Advancing Long-Lasting Immunity against Infectious Diseases. ACS Nano.
Crossref
Crossref
Sneha Raj, Preeti Vishwakarma, Shikha Saxena, Varun Kumar, Ritika Khatri, Amit Kumar, Mrityunjay Singh, Surbhi Mishra, Shailendra Asthana, Shubbir Ahmed & Sweety Samal. (2023) Intradermal Immunization of Soluble Influenza HA Derived from a Lethal Virus Induces High Magnitude and Breadth of Antibody Responses and Provides Complete Protection In Vivo. Vaccines 11:4, pages 780.
Crossref
Crossref
Junhao Luo, Zhuohan Zhang, Song Zhao & Rongbao Gao. (2023) A Comparison of Etiology, Pathogenesis, Vaccinal and Antiviral Drug Development between Influenza and COVID-19. International Journal of Molecular Sciences 24:7, pages 6369.
Crossref
Crossref
Mark D. Langowski, Farhat A. Khan, Sofya Savransky, Dallas R. Brown, Arasu Balasubramaniyam, William B. Harrison, Xiaoyan Zou, Zoltan Beck, Gary R. Matyas, Jason A. Regules, Robin Miller, Lorraine A. Soisson, Adrian H. Batchelor & Sheetij Dutta. (2022) Restricted valency (NPNA)n repeats and junctional epitope-based circumsporozoite protein vaccines against Plasmodium falciparum. npj Vaccines 7:1.
Crossref
Crossref
Olugbenga Oluseun Oluwagbemi, Elijah Kolawole Oladipo, Emmanuel Oluwatobi Dairo, Ayodele Eugene Ayeni, Boluwatife Ayobami Irewolede, Esther Moradeyo Jimah, Moyosoluwa Precious Oyewole, Boluwatife Mary Olawale, Hadijat Motunrayo Adegoke & Adewale Joseph Ogunleye. (2022) Computational construction of a glycoprotein multi-epitope subunit vaccine candidate for old and new South-African SARS-CoV-2 virus strains. Informatics in Medicine Unlocked 28, pages 100845.
Crossref
Crossref
Joshua M. Royal, Carrie A. Simpson, Alison A. McCormick, Amanda Phillips, Steve Hume, Josh Morton, John Shepherd, Youngjun Oh, Kelsi Swope, Jennifer L. DeBeauchamp, Richard J. Webby, Robert W. Cross, Viktoriya Borisevich, Thomas W. Geisbert, Jennifer K. Demarco, Barry Bratcher, Hugh Haydon & Gregory P. Pogue. (2021) Development of a SARS-CoV-2 Vaccine Candidate Using Plant-Based Manufacturing and a Tobacco Mosaic Virus-like Nano-Particle. Vaccines 9:11, pages 1347.
Crossref
Crossref
Hadrien Peyret, John F. C. Steele, Jae-Wan Jung, Eva C. Thuenemann, Yulia Meshcheriakova & George P. Lomonossoff. (2021) Producing Vaccines against Enveloped Viruses in Plants: Making the Impossible, Difficult. Vaccines 9:7, pages 780.
Crossref
Crossref
Srividhya Venkataraman, Kathleen Hefferon, Abdullah Makhzoum & Mounir Abouhaidar. (2021) Combating Human Viral Diseases: Will Plant-Based Vaccines Be the Answer?. Vaccines 9:7, pages 761.
Crossref
Crossref
Nina Butkovich, Enya Li, Aaron Ramirez, Amanda M. Burkhardt & Szu‐Wen Wang. (2020) Advancements in protein nanoparticle vaccine platforms to combat infectious disease. WIREs Nanomedicine and Nanobiotechnology 13:3.
Crossref
Crossref
Christina D'Arco, Alison A. McCormick & Paul M. Arnaboldi. (2021) Single-dose intranasal subunit vaccine rapidly clears secondary sepsis in a high-dose pneumonic plague infection. Vaccine 39:9, pages 1435-1444.
Crossref
Crossref
Ekaterina A. Evtushenko, Ekaterina M. Ryabchevskaya, Nikolai A. Nikitin, Joseph G. Atabekov & Olga V. Karpova. (2020) Plant virus particles with various shapes as potential adjuvants. Scientific Reports 10:1.
Crossref
Crossref
Sudeep Kumar, Raju Sunagar & Edmund J. Gosselin. (2020) Preclinical Efficacy of a Trivalent Human FcγRI-Targeted Adjuvant-Free Subunit Mucosal Vaccine against Pulmonary Pneumococcal Infection. Vaccines 8:2, pages 193.
Crossref
Crossref
Jhanvi Sharma, Kelly Shepardson, Laura L. Johns, Julia Wellham, John Avera, Benjamin Schwarz, Agnieszka Rynda-Apple & Trevor Douglas. (2020) A Self-Adjuvanted, Modular, Antigenic VLP for Rapid Response to Influenza Virus Variability. ACS Applied Materials & Interfaces 12:16, pages 18211-18224.
Crossref
Crossref
Paul Eapen, Jennifer Cates, Rich Mundell, Kenneth E. Palmer & Joshua L. Fuqua. (2020) In Preparation for Outdoor Pharming: Griffithsin Can Be Expressed in Nicotiana excelsiana and Retains Activity After Storage as Silage. Frontiers in Bioengineering and Biotechnology 8.
Crossref
Crossref
T. V. Gasanova, A. A. Koroleva, E. V. Skurat & P. A. Ivanov. (2020) Complexes Formed via Bioconjugation of Genetically Modified TMV Particles with Conserved Influenza Antigen: Synthesis and Characterization. Biochemistry (Moscow) 85:2, pages 224-233.
Crossref
Crossref
Tsepo L Tsekoa, Advaita Acarya Singh & Sindisiwe G Buthelezi. (2020) Molecular farming for therapies and vaccines in Africa. Current Opinion in Biotechnology 61, pages 89-95.
Crossref
Crossref
Sangita Venkataraman, Vijay S. Reddy & S. M. Paul Khurana. 2020. NanoBioMedicine. NanoBioMedicine
213
236
.
Mandy Gebauer, Hans C. Hürlimann, Martina Behrens, Thorsten Wolff & Sven-Erik Behrens. (2019) Subunit vaccines based on recombinant yeast protect against influenza A virus in a one-shot vaccination scheme. Vaccine 37:37, pages 5578-5587.
Crossref
Crossref
Mine Aksular, Eva Calvo-Pinilla, Alejandro Marín-López, Javier Ortego, Adam C. Chambers, Linda A. King & Javier Castillo-Olivares. (2018) A single dose of African horse sickness virus (AHSV) VP2 based vaccines provides complete clinical protection in a mouse model. Vaccine 36:46, pages 7003-7010.
Crossref
Crossref
Ahd A. Mansour, Sukalyani Banik, Ragavan V. Suresh, Hardeep Kaur, Meenakshi Malik, Alison A. McCormick & Chandra S. Bakshi. (2018) An Improved Tobacco Mosaic Virus (TMV)-Conjugated Multiantigen Subunit Vaccine Against Respiratory Tularemia. Frontiers in Microbiology 9.
Crossref
Crossref
Alison A. McCormick, Aisha Shakeel, Chris Yi, Hardeep Kaur, Ahd M. Mansour & Chandra Shekhar Bakshi. (2018) Intranasal administration of a two-dose adjuvanted multi-antigen TMV-subunit conjugate vaccine fully protects mice against Francisella tularensis LVS challenge. PLOS ONE 13:4, pages e0194614.
Crossref
Crossref
Qiang Chen, Matthew Dent & Hugh Mason. 2018. Molecular Pharming. Molecular Pharming
231
273
.
Marie-Ève Lebel, Marie-Pierre Langlois, Jean-François Daudelin, Esther Tarrab, Pierre Savard, Denis Leclerc & Alain Lamarre. (2017) Complement Component 3 Regulates IFN-α Production by Plasmacytoid Dendritic Cells following TLR7 Activation by a Plant Virus–like Nanoparticle. The Journal of Immunology 198:1, pages 292-299.
Crossref
Crossref
Paul M. Arnaboldi, Mariya Sambir, Christina D’Arco, Lauren A. Peters, Jos F.M.L. Seegers, Lloyd Mayer, Alison A. McCormick & Raymond J. Dattwyler. (2016) Intranasal delivery of a protein subunit vaccine using a Tobacco Mosaic Virus platform protects against pneumonic plague. Vaccine 34:47, pages 5768-5776.
Crossref
Crossref
Jittima Amie Luckanagul, Kamolrat Metavarayuth, Sheng Feng, Phudit Maneesaay, Amy Y. Clark, Xiaoming Yang, Andrés J. García & Qian Wang. (2016) Tobacco Mosaic Virus Functionalized Alginate Hydrogel Scaffolds for Bone Regeneration in Rats with Cranial Defect. ACS Biomaterials Science & Engineering 2:4, pages 606-615.
Crossref
Crossref
T. V. Gasanova, N. V. Petukhova & P. A. Ivanov. (2016) Chimeric particles of tobacco mosaic virus as a platform for the development of next-generation nanovaccines. Nanotechnologies in Russia 11:3-4, pages 227-236.
Crossref
Crossref
Joshua Powell. (2015) From Pandemic Preparedness to Biofuel Production: Tobacco Finds Its Biotechnology Niche in North America. Agriculture 5:4, pages 901-917.
Crossref
Crossref
Peter Pushko, Lindsey M. Pujanauski, Xiangjie Sun, Melissa Pearce, Rachmat Hidajat, Thomas Kort, Louis M. Schwartzman, Irina Tretyakova, Liu Chunqing, Jeffery K. Taubenberger & Terrence M. Tumpey. (2015) Recombinant H7 hemagglutinin forms subviral particles that protect mice and ferrets from challenge with H7N9 influenza virus. Vaccine 33:38, pages 4975-4982.
Crossref
Crossref
Marie-Ève Lebel, Karine Chartrand, Denis Leclerc & Alain Lamarre. (2015) Plant Viruses as Nanoparticle-Based Vaccines and Adjuvants. Vaccines 3:3, pages 620-637.
Crossref
Crossref
Sukalyani Banik, Ahd Ahmed Mansour, Ragavan Varadharajan Suresh, Sherri Wykoff-Clary, Meenakshi Malik, Alison A. McCormick & Chandra Shekhar Bakshi. (2015) Development of a Multivalent Subunit Vaccine against Tularemia Using Tobacco Mosaic Virus (TMV) Based Delivery System. PLOS ONE 10:6, pages e0130858.
Crossref
Crossref
Yiyang Zhou, Payal D. Maharaj, Jyothi K. Mallajosyula, Alison A. McCormick & Christopher M. Kearney. (2014) In planta Production of Flock House Virus Transencapsidated RNA and Its Potential Use as a Vaccine. Molecular Biotechnology 57:4, pages 325-336.
Crossref
Crossref
Naru Zhang, Bo-Jian Zheng, Lu Lu, Yusen Zhou, Shibo Jiang & Lanying Du. (2015) Advancements in the development of subunit influenza vaccines. Microbes and Infection 17:2, pages 123-134.
Crossref
Crossref
Edward P Rybicki. (2014) Plant-based vaccines against viruses. Virology Journal 11:1.
Crossref
Crossref
Payal Maharaj, Jyothi Mallajosyula, Gloria Lee, Phillip Thi, Yiyang Zhou, Christopher Kearney & Alison McCormick. (2014) Nanoparticle Encapsidation of Flock House Virus by Auto Assembly of Tobacco Mosaic Virus Coat Protein. International Journal of Molecular Sciences 15:10, pages 18540-18556.
Crossref
Crossref
Jan Ole Kemnade, Mamatha Seethammagari, Mathew Collinson-Pautz, Hardeep Kaur, David M. Spencer & Alison A. McCormick. (2014) Tobacco mosaic virus efficiently targets DC uptake, activation and antigen-specific T cell responses in vivo. Vaccine 32:33, pages 4228-4233.
Crossref
Crossref